World News: 13:00 GMT Friday 9th November 2018. [Neon Therapeutics, Inc. via Globe Newswire via SPi World News]
CAMBRIDGE Mass Nov 09 2018 GLOBE NEWSWIRE -- Neon Therapeutics Inc (Nasdaq: NTGN a clinical-stage immuno-oncology company developing neoantigen-based therapeuticstoday presents updated data from NT-001 its ongoing Phase 1b clinica l trial...
Globe Newswire: 13:00 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.